drugset / Trial / NCT02523300
Glucocorticoid on the Prognosis of TEVAR
RandomizedParallel-groupOpen-labelPrevention
Summary
To explore the potential prognostic effect of glucocorticoid on the postoperative aorta-related adverse events after aortic dissections patients underwent thoracic endovascular aortic repair (TEVAR), glucocorticoid (30mg/kg) will be intravenously given within 2h after TEVAR.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-09
- Completion
- 2019-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | 30 mg/kg | Intravenous |